Overview
Infantile thalamic degeneration is an extremely rare neurological condition that was historically described in infants and involves the progressive breakdown (degeneration) of the thalamus, a key structure deep in the brain. The thalamus acts as a relay station for sensory and motor signals and plays important roles in consciousness, sleep, and alertness. When this area degenerates in infancy, it can lead to severe neurological problems including loss of developmental milestones, seizures, movement abnormalities, and progressive decline in brain function. This condition is now classified as 'obsolete' in medical databases, meaning that with advances in genetic testing and neuroimaging, cases previously grouped under this name have likely been reclassified into more specific diagnoses such as other forms of infantile neurodegeneration or specific genetic conditions affecting the thalamus. Because of its obsolete classification, very limited modern clinical data is available. Families who were given this diagnosis in the past are encouraged to seek updated genetic evaluation, as newer testing methods may identify a more precise underlying cause, which could open doors to more targeted management or emerging therapies. Treatment has historically been supportive, focusing on seizure control, nutritional support, and comfort care.
Key symptoms:
Loss of previously learned skills (developmental regression)SeizuresAbnormal muscle tone (stiffness or floppiness)Difficulty feeding or swallowingIrritability or excessive cryingLoss of awareness or responsivenessAbnormal eye movementsFailure to thrive or poor weight gainMovement problems such as jerking or tremorsProgressive decline in brain function
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Infantile thalamic degeneration.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Infantile thalamic degeneration at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Infantile thalamic degeneration.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Infantile thalamic degeneration.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Infantile thalamic degeneration.
Start the conversation →Latest news about OBSOLETE: Infantile thalamic degeneration
No recent news articles for OBSOLETE: Infantile thalamic degeneration.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has modern genetic testing been done to identify a more specific diagnosis for my child?,Are there any treatable conditions that could explain my child's symptoms?,What is the best plan for managing my child's seizures?,Should we consider palliative care services, and when should we start?,What is the recurrence risk for future pregnancies, and should we see a genetic counselor?,Are there any clinical trials or research studies that might be relevant?,What support services are available for our family?
Common questions about OBSOLETE: Infantile thalamic degeneration
What is OBSOLETE: Infantile thalamic degeneration?
Infantile thalamic degeneration is an extremely rare neurological condition that was historically described in infants and involves the progressive breakdown (degeneration) of the thalamus, a key structure deep in the brain. The thalamus acts as a relay station for sensory and motor signals and plays important roles in consciousness, sleep, and alertness. When this area degenerates in infancy, it can lead to severe neurological problems including loss of developmental milestones, seizures, movement abnormalities, and progressive decline in brain function. This condition is now classified as 'o
At what age does OBSOLETE: Infantile thalamic degeneration typically begin?
Typical onset of OBSOLETE: Infantile thalamic degeneration is infantile. Age of onset can vary across affected individuals.